tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Compare Ascendis Pharma (ASND) vs. Competitors

Compare
691 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ascendis Pharma
$221.88
$13.62B
-50.22
35.92%
13 Buy
0 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$54.13
$10.41B
32.67
-24.40%
13 Buy
3 Hold
0 Sell
Strong Buy
Exelixis
$41.27
$10.72B
12.10
11.00%
6 Buy
7 Hold
1 Sell
Moderate Buy
Madrigal Pharmaceuticals
$441.16
$10.12B
31.64%
8 Buy
2 Hold
0 Sell
Strong Buy
United Therapeutics
$524.28
$22.98B
16.17
67.18%
9 Buy
4 Hold
0 Sell
Moderate Buy
BridgeBio Pharma
$68.54
$13.29B
-20.69
102.12%
18 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ASND
Ascendis Pharma
221.88
53.89
32.08%
BMRN
BioMarin Pharmaceutical
54.13
-17.86
-24.81%
EXEL
Exelixis
41.27
3.55
9.41%
MDGL
Madrigal Pharmaceuticals
441.16
94.76
27.36%
UTHR
United Therapeutics
524.28
204.42
63.91%
BBIO
BridgeBio Pharma
68.54
31.32
84.15%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts